Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Racemic Ketamine Versus Esketamine (Spravato®) for Depression: The OBSERVE Protocol

NCT06725277 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06725277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06725277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Racemic Ketamine Versus Esketamine (Spravato®) for Depression: The OBSERVE Protocol
Lead sponsor
Yale University
Phase
Observational
Overall status
Recruiting
Start date
January 21, 2024
Completion date
December 31, 2029
Enrollment
450 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

major depression disorder